Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Eva Molina
Observed name:
E. Molina
Institution:
Centro de Investigación Médica Aplicada
Observed institutions:
Universidad de Salamanca,
Instituto de Salud Carlos III,
Navarre Institute of Health Research,
Instituto de Investigación Biomédica de Salamanca,
Clinica Universidad de Navarra,
Centro de Investigación Médica Aplicada,
Universidad de Navarra
show all 7
ORCID:
0000-0002-5989-2117
Observed ORCID:
0000-0002-5989-2117
OpenAlex ID:
A5086355137
Differential effects of 2C9*3 and 2C9*2 variants of cytochrome P-450 CYP2C9 on sensitivity to acenocoumarol
2002
·
José Hermida
, José Zarza
, et al.
·
Blood
·
86
PDF
VEGF121b and VEGF165b are weakly angiogenic isoforms of VEGF-A
2010
·
Raúl Catena
, Leyre Larzabal
, et al.
·
Molecular Cancer
·
79
PDF
Receptor of Activated Protein C Promotes Metastasis and Correlates with Clinical Outcome in Lung Adenocarcinoma
2012
·
Iker Antón
, Eva Molina
, et al.
·
American Journal of Respiratory and Critical Care Medicine
·
60
Hsp70 protects from stroke in atrial fibrillation patients by preventing thrombosis without increased bleeding risk
2016
·
Mikel Allende
, Eva Molina
, et al.
·
Cardiovascular Research
·
58
Short Leukocyte Telomere Length Is Associated With Cardioembolic Stroke Risk in Patients With Atrial Fibrillation
2016
·
Mikel Allende
, Eva Molina
, et al.
·
Stroke
·
31
PDF
Is EPCR a multi-ligand receptor? Pros and cons
2012
·
Eva Molina
, José Hermida
, et al.
·
Thrombosis and Haemostasis
·
29
The functional properties of a truncated form of endothelial cell protein C receptor generated by alternative splicing
2008
·
E. Molina
, J. Hermida
, et al.
·
Haematologica
·
13
PDF
Inducing heat shock protein 70 expression provides a robust anti-thrombotic effect with minimal bleeding risk
2017
·
Mikel Allende
, Eva Molina
, et al.
·
Thrombosis and Haemostasis
·
11
Discovery and preclinical development of a SdAb-based CAR-T technology for targeting CD33 in AML
2025
·
Franco Bernasconi-Bisio
, Eva Molina
, et al.
·
Molecular Therapy Oncology
·
9
CYP2C9 on sensitivity to acenocoumarol Differential effects of 2C9*3 and 2C9*2 variants of cytochrome P-450
2012
·
José Hermida
, José Zarza
, et al.
·
2
Predisposición genética al sangrado durante el tratamiento con anticoagulantes orales
2008
·
R. Montes
, O. Nantes
, et al.
·
Anales del Sistema Sanitario de Navarra
·
1
PDF
Rational engineering of sdAb-based CAR T cells targeting BCMA enhances antitumor efficacy and persistence in Multiple Myeloma
2026
·
Vianca Ibarra-García
, Maria E. Calleja-Cervantes
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
Innovative sdab-based CAR-T cells targeting BCMA outperform current CAR-T therapies for multiple myeloma
2025
·
Vianca Ibarra-Garcia
, Maria Erendira Calleja-Cervantes
, et al.
·
Blood
Association of matrix metalloproteinase-10 levels and genetic variant rs17860955 with severe vascular complications in patients with type 1 diabetes: prospective cohort
2025
·
J.M. Zubiria
, E. Molina
, et al.
·
Journal of Diabetes and its Complications
Abstract 5688: DSTYK dependent regulation of autophagy protects against TNF alpha induced apoptosis in lung cancer
2025
·
Andrea Pasquier
, Cristina Viu-Idocin
, et al.
·
Cancer Research
Identification and Evaluation of Novel Sdab-Based CAR-T Cells Against BCMA with Improved Therapeutic Efficacy for Multiple Myeloma
2024
·
Vianca Ibarra-Garcia
, Eva Molina
, et al.
·
Blood
DSTYK-Dependent Modulation of Autophagy Prevents TNF-α-Induced Apoptosis in Lung Cancer
2024
·
Andrea Pasquier
, Beñat Picabea
, et al.
·
SSRN Electronic Journal
Show more works
View as search
Works count:
17
Citation count:
379
H-index:
9
I10-index:
8
Year
Topic
Type